Conversely, SRY overexpression in the female cancer cell lines U2OS and HeLa and in the male normal ARPE-19 cells is sufficient to reduce the accumulation of TSPYL2 at both 24 and 48 h after etoposide treatment (Fig. 4C). Here, SRY is linked to cancer.